Longboard Pharmaceuticals Inc (LBPH) Stock Income Statement
USA - NASDAQ:LBPH - US54300N1037 - Common Stock
59.98 USD
+0.02 (+0.03%)
60.01 USD
+0.03 (+0.05%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 87.45M | 56.76M | 44.80M | 27.84M | 14.40M | |||
| Research and Development | 67.26M | 43.75M | 34.64M | 19.77M | 4.63M | |||
| Selling, General, and Administrative Expenses | 20.19M | 13.01M | 10.16M | 8.07M | 9.77M | |||
| Operating Income | -87.45M | -56.76M | -44.80M | -27.84M | -14.40M | |||
| Interest Income/Expense | 11.26M | 2.40M | 840.00K | 60.00K | N/A | |||
| Other Income/Expense | -154.00K | -68.00K | 20.00K | -20.00K | N/A | |||
| Income Before Taxes | -76.34M | -54.42M | -43.95M | -27.80M | -14.40M | |||
| Net Income | -76.34M | -54.42M | -43.95M | -27.80M | -14.40M | |||
| EBITDA | -87.44M | -56.75M | -44.79M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.24 | -2.39 | -2.56 | -1.93 | -0.85 | |||
| Non GAAP EPS | -2.23 | -2.38 | -2.57 | -2.15 | N/A | |||
| Statistics | ||||||||
All data in USD